按回车键搜索，或按 ESC 键关闭

关闭搜索

解决方案
软件
服务
客户
客户
资源
公司
联系我们
登录

搜索

菜单

English 日本語简体中文

解决方案
软件
服务
客户
资源
公司
联系我们
登录

搜索

解决方案
软件
服务
客户
资源
公司
联系我们
登录

Home / Resources / Case Studies

案例研究

及时了解最新资源

Featured case study

All Case Study LP - featured

重塑医药未来：Biohaven 公司 Nurtec™ 药物的研发之旅

In February 2020, Biohaven Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) approved Nurtec™ (Rimegepant) for the acute treatment of migraines in…

Latest case studies

All Case Study

Securing Pimicotinib Approval: How Abbisko Therapeutics Successfully Completed its NMPA and FDA Submissions with Pinnacle 21 Enterprise

Securing Pimicotinib Approval: How Abbisko Therapeutics Successfully Completed its NMPA and FDA Submissions with Pinnacle 21 Enterprise

Learn how Abbisko Therapeutics improved regulatory readiness and accelerated its path to…

De-Risking Phase 3 Rheumatoid Arthritis Trials with Model-Based Meta-Analysis (MBMA)

De-Risking Phase 3 Rheumatoid Arthritis Trials with Model-Based Meta-Analysis (MBMA)

Learn how Model-based meta-analysis (MBMA) helped optimize Phase 3 trial design, dose…

63 次迭代仍未收敛：When RsNLME succeeded where other PK/PD solutions couldn’t

63 次迭代仍未收敛：When RsNLME succeeded where other PK/PD solutions couldn’t

After 63 failed runs on a 16-ODE neutropenia model, RsNLME achieved PK/PD…

Popular case studies

All Case Study

Model-Informed Development Accelerates Transformative Treatment for Sleeping Sickness

Model-Informed Development Accelerates Transformative Treatment for Sleeping Sickness

How Certara Enabled Fruquintinib FDA Approval for Metastatic Colorectal Cancer

How Certara Enabled Fruquintinib FDA Approval for Metastatic Colorectal Cancer

Integrated PK/PD Modeling and Machine Learning to Support CNS Compound Selection

Integrated PK/PD Modeling and Machine Learning to Support CNS Compound Selection

Accelerated ADC Approval Through Expert Modeling and Data Rescue

Accelerated ADC Approval Through Expert Modeling and Data Rescue

Merck Advances Pediatric Oncology with Innovative ADC Modeling

Merck Advances Pediatric Oncology with Innovative ADC Modeling

How a Global Pharma Leader Transformed Chemical Data Management with Marvin, Chemaxon’s chemical editor

How a Global Pharma Leader Transformed Chemical Data Management with Marvin, Chemaxon’s chemical editor

All case studies

Merck Advances Pediatric Oncology with Innovative ADC Modeling

Validation in clinical data management: MacroGenics® Optimizes Validation and Issue Management with Pinnacle 21® Enterprise

How Certara and TrialAssure Partner to Deliver Faster, Compliant Anonymization for Global Sponsors

Certara 与迪哲强强联手助力舒沃替尼斩获FDA肺癌适应症加速批准

Biogen 利用 Certara 元数据管理重构临床研究管理

杜氏肌营养不良症（DMD）药物研发中的剂量优化与监管结果优化

Be the first to get the latest

Transforming drug development is not just our goal—it’s our obsession. 如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。

订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。

快捷链接

品牌故事
投资者关系
招贤纳士
办公地点
新闻
服务
软件
资源

解决方案

监管审批
Non-Animal Navigator™
药物发现
临床前
早期临床
晚期临床
市场准入与商业
战略领导力

联系我们

销售查询
技术支持中心

x-twitter
facebook
linkedin
youtube